NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Healionics Corporation

Healionics Corporation

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://healionics.com/

Last Round

Grant

May 9, 2024

Total Funding Raised

$23.45M

Company Overview

Healionics Corporation is a biotechnology company that develops innovative biomaterial-based medical devices, including the STARgraft vascular graft for dialysis patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biomaterialvascular accessmedical deviceSTARgraftporous scaffoldhemodialysistissue integrationimplantable deviceforeign body responsebiotechmedtechvascular graftbiomaterials sciencemedical implantregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Healionics Corporation Comps

Public and private peers based on sector, stage, and business model.

Healionics Corporation comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Healionics Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 9, 2024
Series A ExtensionFeb 22, 2024
Series A ExtensionMay 13, 2021
Convertible DebtSep 24, 2019
VC RoundFeb 28, 2019
Grant
Nov 16, 2017

Key People

Founding team and executive leadership

Mike Connolly

CEO & Chairman

Executive Team

Andrew J Marshall

Chief Technology Officer, Director

Executive Team

Healionics Corporation Investors

Notable investors and investment history

Healionics Corporation investors
InvestorRounds
Keiretsu ForumSeries A Extension
NIH RADxGrant
Alliance of AngelsSeries B
Bellingham Angel InvestorsSeries B
Keiretsu CapitalSeries A Extension
National Heart, Lung, and Blood InstituteGrant
TCA Venture GroupConvertible Debt

Healionics Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Healionics Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Healionics Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range9
Year Founded2007
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.